ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TRDA Entrada Therapeutics Inc

12.89
-0.06 (-0.46%)
Apr 15 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 108,935
Bid Price 10.40
Ask Price 13.44
News -
Day High 13.543

Low
10.62

52 Week Range

High
18.44

Day Low 12.69
Company Name Stock Ticker Symbol Market Type
Entrada Therapeutics Inc TRDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -0.46% 12.89 20:00:00
Open Price Low Price High Price Close Price Prev Close
13.03 12.69 13.543 12.89 12.95
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,155 108,935 $ 13.18 $ 1,435,917 - 10.62 - 18.44
Last Trade Time Type Quantity Stock Price Currency
16:08:48 formt 51,097 $ 12.89 USD

Entrada Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
432.78M 33.60M - 129.01M -6.69M -0.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Entrada Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TRDA Message Board. Create One! See More Posts on TRDA Message Board See More Message Board Posts

Historical TRDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week13.8914.1312.1812.9591,291-1.00-7.20%
1 Month12.7814.5112.1813.4370,5770.110.86%
3 Months15.0316.5011.3513.5775,019-2.14-14.24%
6 Months13.3117.5810.750114.1578,724-0.42-3.16%
1 Year17.2618.4410.6214.4478,847-4.37-25.32%
3 Years26.5036.855.1215.1987,864-13.61-51.36%
5 Years26.5036.855.1215.1987,864-13.61-51.36%

Entrada Therapeutics Description

Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases.

Your Recent History

Delayed Upgrade Clock